123 related articles for article (PubMed ID: 23845778)
41. Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.
Sejas DP; Rani R; Qiu Y; Zhang X; Fagerlie SR; Nakano H; Williams DA; Pang Q
J Immunol; 2007 Apr; 178(8):5277-87. PubMed ID: 17404312
[TBL] [Abstract][Full Text] [Related]
42. Mutated Fanconi anemia pathway in non-Fanconi anemia cancers.
Shen Y; Lee YH; Panneerselvam J; Zhang J; Loo LW; Fei P
Oncotarget; 2015 Aug; 6(24):20396-403. PubMed ID: 26015400
[TBL] [Abstract][Full Text] [Related]
43. Increased IL10 plasmatic levels in Fanconi anemia patients.
Justo GA; Bitencourt MA; Pasquini R; Castelo-Branco MT; Rumjanek VM
Cytokine; 2013 Nov; 64(2):486-9. PubMed ID: 24021704
[TBL] [Abstract][Full Text] [Related]
44. Leukemia and chromosomal instability in aged Fancc-/- mice.
Cerabona D; Sun Z; Nalepa G
Exp Hematol; 2016 May; 44(5):352-7. PubMed ID: 26860989
[TBL] [Abstract][Full Text] [Related]
45. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.
Li J; Sejas DP; Zhang X; Qiu Y; Nattamai KJ; Rani R; Rathbun KR; Geiger H; Williams DA; Bagby GC; Pang Q
J Clin Invest; 2007 Nov; 117(11):3283-95. PubMed ID: 17960249
[TBL] [Abstract][Full Text] [Related]
46. Fanconi Anemia complementation group C protein in metabolic disorders.
Nepal M; Ma C; Xie G; Jia W; Fei P
Aging (Albany NY); 2018 Jun; 10(6):1506-1522. PubMed ID: 29930218
[TBL] [Abstract][Full Text] [Related]
47. Increased Fanconi C expression contributes to the emergency granulopoiesis response.
Hu L; Huang W; Hjort E; Eklund EA
J Clin Invest; 2013 Sep; 123(9):3952-66. PubMed ID: 23925293
[TBL] [Abstract][Full Text] [Related]
48. The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific.
Dai MS; Chevallier N; Stone S; Heinrich MC; McConnell M; Reuter T; Broxmeyer HE; Licht JD; Lu L; Hoatlin ME
J Biol Chem; 2002 Jul; 277(29):26327-34. PubMed ID: 11986317
[TBL] [Abstract][Full Text] [Related]
49. Impaired immune response to Candida albicans in cells from Fanconi anemia patients.
Parodi A; Kalli F; Svahn J; Stroppiana G; De Rocco D; Terranova P; Dufour C; Fenoglio D; Cappelli E
Cytokine; 2015 May; 73(1):203-7. PubMed ID: 25769809
[TBL] [Abstract][Full Text] [Related]
50. Loss of Fancc Impairs Antibody-Secreting Cell Differentiation in Mice through Deregulating the Wnt Signaling Pathway.
Sertorio M; Amarachintha S; Wilson A; Pang Q
J Immunol; 2016 Apr; 196(7):2986-94. PubMed ID: 26895835
[TBL] [Abstract][Full Text] [Related]
51. Mitotic Errors Promote Genomic Instability and Leukemia in a Novel Mouse Model of Fanconi Anemia.
Edwards DM; Mitchell DK; Abdul-Sater Z; Chan KK; Sun Z; Sheth A; He Y; Jiang L; Yuan J; Sharma R; Czader M; Chin PJ; Liu Y; de Cárcer G; Nalepa G; Broxmeyer HE; Clapp DW; Sierra Potchanant EA
Front Oncol; 2021; 11():752933. PubMed ID: 34804941
[TBL] [Abstract][Full Text] [Related]
52. Impaired function of Fanconi anemia type C-deficient macrophages.
Liu Y; Ballman K; Li D; Khan S; Derr-Yellin E; Shou W; Haneline LS
J Leukoc Biol; 2012 Feb; 91(2):333-40. PubMed ID: 22106009
[TBL] [Abstract][Full Text] [Related]
53. A Global MicroRNA Profile in Fanconi Anemia: A Pilot Study.
Degan P; Cappelli E; Longobardi M; Pulliero A; Cuccarolo P; Dufour C; Ravera S; Calzia D; Izzotti A
Metab Syndr Relat Disord; 2019 Feb; 17(1):53-59. PubMed ID: 30376422
[TBL] [Abstract][Full Text] [Related]
54. NK Cell Development and Function in Patients with Fanconi Anemia.
Hashemi E; Bjorgaard S; Wang D; Uyemura B; Riese M; Thakar MS; Malarkannan S
Crit Rev Immunol; 2021; 41(2):35-44. PubMed ID: 34348001
[TBL] [Abstract][Full Text] [Related]
55. A systems biology approach for elucidating the interaction of curcumin with Fanconi anemia FANC G protein and the key disease targets of leukemia.
Mahato D; Samanta D; Mukhopadhyay SS; Krishnaraj RN
J Recept Signal Transduct Res; 2017 Jun; 37(3):276-282. PubMed ID: 27608133
[TBL] [Abstract][Full Text] [Related]
56. Oxidant hypersensitivity of Fanconi anemia type C-deficient cells is dependent on a redox-regulated apoptotic pathway.
Saadatzadeh MR; Bijangi-Vishehsaraei K; Hong P; Bergmann H; Haneline LS
J Biol Chem; 2004 Apr; 279(16):16805-12. PubMed ID: 14764578
[TBL] [Abstract][Full Text] [Related]
57. Cytogenetic characteristics of oral squamous cell carcinomas in Fanconi anemia.
Hermsen MA; Xie Y; Rooimans MA; Meijer GA; Baak JP; Plukker JT; Arwert F; Joenje H
Fam Cancer; 2001; 1(1):39-43. PubMed ID: 14574014
[TBL] [Abstract][Full Text] [Related]
58. Aberrant activation of stress-response pathways leads to TNF-alpha oversecretion in Fanconi anemia.
Briot D; Macé-Aimé G; Subra F; Rosselli F
Blood; 2008 Feb; 111(4):1913-23. PubMed ID: 18055871
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients.
Ghazwani Y; AlBalwi M; Al-Abdulkareem I; Al-Dress M; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Essa M; Al-Zahrani M; Alsultan A
Cancer Genet; 2016 Apr; 209(4):171-6. PubMed ID: 26968956
[TBL] [Abstract][Full Text] [Related]
60. Fanconi anaemia research: current status and prospects.
Joenje H; Mathew C; Gluckman E
Eur J Cancer; 1995; 31A(2):268-72. PubMed ID: 7718336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
